Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Xortx Therapeutics Inc (XRTX.VN)

Xortx Therapeutics Inc (XRTX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,286
  • Shares Outstanding, K 3,224
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,158 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.66
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $0.06 on 08/15/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

    TSX Bottom 100 Stocks

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.800 +8.33%
on 11/15/24
3.290 -40.73%
on 10/16/24
-0.580 (-22.92%)
since 10/15/24
3-Month
1.540 +26.62%
on 08/28/24
3.880 -49.74%
on 08/29/24
-0.010 (-0.51%)
since 08/15/24
52-Week
1.540 +26.62%
on 08/28/24
9.350 -79.14%
on 03/07/24
-1.300 (-40.00%)
since 11/15/23

Most Recent Stories

More News
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)
XORTX Initiates Precision Medicine Program

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)
Stocks in play: XORTX Therapeutics Inc.

Announces that it has received TSX Venture Exchange approval to amend the terms of the balance of outstanding ...

XRTX.VN : 1.950 (unch)
Stocks in play: XORTX Therapeutics Inc

Announced the grant of Orphan Drug Designation for oxypurinol – “orphan-drug designation request of ...

XRTX.VN : 1.950 (unch)
XORTX Announces Submission to European Medicines Agency

Scientific Advice from EMA Committee for Medicinal Products for Human Use Requested...

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial

Clinical Trial Shows Substantially Improved Bioavailiability...

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)
XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)
XORTX to Present at BIO International Convention 2022

CALGARY, Alberta, June 13, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.950 (unch)
XRTX : 1.3250 (-5.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as...

See More

Key Turning Points

3rd Resistance Point 2.130
2nd Resistance Point 2.070
1st Resistance Point 2.010
Last Price 1.950
1st Support Level 1.890
2nd Support Level 1.830
3rd Support Level 1.770

See More

52-Week High 9.350
Fibonacci 61.8% 6.367
Fibonacci 50% 5.445
Fibonacci 38.2% 4.523
Last Price 1.950
52-Week Low 1.540

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar